Porth Ymchwil

All Wales Medicines Strategy Group Final Appraisal Report - Abacavir 600mg/lamivudine 300mg (Kivexa) in antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus infection in adults and adolescents from 12 years of age.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

  • D. Hughes
  • D.A. Hughes
  • [No Value] All Wales Strategy Group.
Iaith wreiddiolSaesneg
CyhoeddwrUnknown
Corff comisiynuNHS Wales
Argraffiad2008
StatwsCyhoeddwyd - 1 Ion 2008
Gweld graff cysylltiadau